Therefore, HBx and AFB1 mediated COX‐2 up‐regulation was required for MLKL to be recruited to RIP3 for subsequent execution of necroptosis, and COX‐2 could serve as a potential therapeutic target for necrotic cell death‐associated hepatic steatosis. The gene discussed is RIPK3; the disease is fatty liver disease.